Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$95.6M Buy
794,868
+21,150
+3% +$2.44M 0.74% 21
2025
Q4
$81.4M Buy
773,718
+59,725
+8% +$5.61M 0.58% 30
2025
Q3
$59.9M Buy
713,993
+100,798
+16% +$8.3M 0.43% 39
2025
Q2
$48.5M Buy
613,195
+113,220
+23% +$9M 0.39% 51
2025
Q1
$44.9M Buy
499,975
+112,579
+29% +$10.5M 0.41% 49
2024
Q4
$38.5M Buy
387,396
+28,910
+8% +$2.98M 0.31% 65
2024
Q3
$40.7M Sell
358,486
-35,872
-9% -$4.26M 0.28% 66
2024
Q2
$48.8M Sell
394,358
-55,875
-12% -$7.2M 0.35% 51
2024
Q1
$59.4M Sell
450,233
-112,727
-20% -$13.9M 0.42% 37
2023
Q4
$61.4M Sell
562,960
-39,715
-7% -$4.12M 0.46% 33
2023
Q3
$62M Sell
602,675
-136,123
-18% -$14.7M 0.53% 21
2023
Q2
$85.2M Sell
738,798
-103,694
-12% -$11.8M 0.67% 12
2023
Q1
$89.6M Sell
842,492
-88,587
-10% -$9.56M 0.75% 11
2022
Q4
$103M Sell
931,079
-69,545
-7% -$7.11M 0.91% 4
2022
Q3
$86.2M Sell
1,000,624
-244
-0% -$21.8K 0.79% 8
2022
Q2
$91.2M Buy
1,000,868
+5,949
+0.6% +$527K 0.72% 9
2022
Q1
$81.6M Buy
994,919
+78,527
+9% +$6.19M 0.49% 25
2021
Q4
$70.2M Buy
916,392
+39,983
+5% +$3.18M 0.37% 39
2021
Q3
$65.8M Buy
876,409
+110,834
+14% +$8.43M 0.4% 30
2021
Q2
$59.5M Buy
765,575
+51,424
+7% +$3.82M 0.35% 38
2021
Q1
$52.5M Buy
714,151
+80,509
+13% +$5.94M 0.34% 42
2020
Q4
$49.5M Buy
633,642
+79,768
+14% +$6.1M 0.31% 45
2020
Q3
$43.8M Buy
553,874
+78,662
+17% +$6.16M 0.32% 51
2020
Q2
$35.1M Buy
475,212
+13,558
+3% +$1.02M 0.27% 64
2020
Q1
$33.9M Sell
461,654
-84,388
-15% -$6.63M 0.34% 46
2019
Q4
$47.4M Buy
546,042
+9,534
+2% +$783K 0.36% 41
2019
Q3
$43.1M Sell
536,508
-45,115
-8% -$3.62M 0.34% 40
2019
Q2
$46.5M Sell
581,623
-6,069
-1% -$465K 0.38% 36
2019
Q1
$46.6M Sell
587,692
-130,121
-18% -$9.73M 0.38% 30
2018
Q4
$52.3M Buy
717,813
+40,719
+6% +$2.87M 0.44% 21
2018
Q3
$45.8M Buy
677,094
+101,688
+18% +$6.48M 0.3% 43
2018
Q2
$33.3M Sell
575,406
-1,109,775
-66% -$62.6M 0.22% 55
2018
Q1
$87.6M Buy
1,685,181
+70,563
+4% +$3.81M 0.21% 64
2017
Q4
$86.7M Buy
1,614,618
+145,495
+10% +$8.07M 0.21% 72
2017
Q3
$89.8M Buy
1,469,123
+19,308
+1% +$1.17M 0.21% 46
2017
Q2
$88.7M Sell
1,449,815
-3,801
-0.3% -$231K 0.23% 52
2017
Q1
$88.1M Sell
1,453,616
-69,984
-5% -$4.25M 0.24% 44
2016
Q4
$85.6M Buy
1,523,600
+254,327
+20% +$14.9M 0.24% 42
2016
Q3
$75.6M Sell
1,269,273
-152,587
-11% -$8.92M 0.24% 49
2016
Q2
$78.2M Sell
1,421,860
-258,915
-15% -$13.8M 0.25% 49
2016
Q1
$84.9M Buy
1,680,775
+67,347
+4% +$3.3M 0.27% 35
2015
Q4
$81.3M Buy
1,613,428
+140,167
+10% +$7.07M 0.24% 54
2015
Q3
$69.4M Sell
1,473,261
-175,089
-11% -$9.3M 0.21% 65
2015
Q2
$89.5M Sell
1,648,350
-132,468
-7% -$7.43M 0.22% 52
2015
Q1
$97.7M Buy
1,780,818
+304,366
+21% +$17.2M 0.23% 45
2014
Q4
$80M Buy
1,476,452
+22,965
+2% +$1.28M 0.2% 76
2014
Q3
$82.2M Buy
1,453,487
+60,572
+4% +$3.4M 0.2% 69
2014
Q2
$76.9M Sell
1,392,915
-94,859
-6% -$5.17M 0.19% 73
2014
Q1
$80.6M Sell
1,487,774
-95,341
-6% -$4.94M 0.23% 52
2013
Q4
$75.6M Buy
1,583,115
+100,277
+7% +$4.58M 0.23% 51
2013
Q3
$67.4M Sell
1,482,838
-1,715
-0.1% -$78.3K 0.24% 41
2013
Q2
$65.8M Buy
+1,484,553
New +$66.3M 0.28% 32

Other funds holding MRK

Guggenheim Capital's MRK Position: Q1 2026 in Review

Guggenheim Capital increased its Merck (MRK) stake by 2.7% in Q1 2026, buying an estimated $2.44M and bringing the position to 794,868 shares worth $95.6M. The position accounts for 0.74% of the portfolio, ranked #21.

Guggenheim Capital first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $103M in Q4 2022. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Guggenheim Capital held 794,868 shares of Merck worth $95.6M as of Q1 2026.
  • Guggenheim Capital bought 21,150 Merck shares in Q1 2026, an estimated $2.44M.
  • Merck made up 0.74% of Guggenheim Capital's portfolio in Q1 2026, its #21 holding.
  • Guggenheim Capital first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Guggenheim Capital's Merck position peaked at $103M in Q4 2022.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.